Background Encephalitis has many causes, but for most patients the cause is unknown. We aimed to establish the cause and identify the clinical diff erences between causes in patients with encephalitis in England.
Introduction
Few high-quality population-based studies of encephalitis are done because the syndrome is rare. Worldwide, up to 85% of cases are of unknown cause, and there is concern about new and emerging triggers. 1, 2 Over the past decade, emerging viruses implicated in causing encephalitis include the Nipah virus, bat lyssaviruses, and avian infl uenza A H5N1. [3] [4] [5] The case of West Nile virus in North America shows the potential for infections to become established in new regions if vectors are present, if avian hosts are susceptible, and if the environment is supportive. 6 In the UK, cases of West Nile virus in human beings can pass undetected because the infection is not endemic and so clinicians might not consider this diagnosis. 7 Furthermore, the contribution of recently described immune-mediated forms of encephalitis, such as those associated with voltage-gated potassium channels and the N-methyl-D-aspartate (NMDA) receptor antibodies, [8] [9] [10] [11] is unclear. Encephalitis is associated with high morbidity and mortality. An estimated 700 cases of viral encephalitis occur yearly in England, of which about 7% are fatal; however, both the incidence and case fatality are thought to be underestimated. 1 If infection is not fatal, individuals often have severe physical, cognitive, emotional, behavioural, and social diffi culties. 12 In the USA, the yearly national costs of patients taken to hospital with encephalitisassociated illness has been estimated at US$630 million. 13 Eff ective interventions exist for some causes of encephalitis. Vaccination against mumps, measles, and rubella has substantially reduced the number of encephalitis cases associated with these diseases. 14 Of the viral causes, herpes simplex virus and varicella zoster virus have well established antiviral treatments, and immunomodulation is used to treat patients with acute disseminated encephalomyelitis (ADEM) or other immune-mediated encephalitides. 15 Timely and appropriate treatment is crucial for improving acute encephalitis outcome; hence, rapid identifi cation of the cause is key.
We present the clinical and aetiological results of a prospective study of 203 patients with encephalitis in England. We aimed to establish the cause by a systematic diagnostic algorithm and expert review process, ascertain clinical diff erences between causes, document the outcome, and establish a well defi ned cohort for future study.
Methods

Patients
We recruited patients for 2 years (staged start between October, 2005, and November, 2006) from 24 hospitals in three regions of England: London, the southwest, and the northwest of England. 16 These regions diff er in socioeconomic and urban-rural characteristics, and comprise an estimated 11% (5 million people) of the English population. Patients were recruited by active promotion and through review of cerebrospinal fl uid (CSF) analysis requests to pathology departments. We interviewed patients or next-of-kin about specifi c exposures, contact with any individuals with infection, risk factors, and travel or illnesses before symptom onset.
The case defi nition included any person of any age admitted to hospital with encephalopathy (altered consciousness that persisted for longer than 24 h, including lethargy, irritability, or a change in personality and behaviour) and with two or more of the following: fever or history of fever (≥38ºC) during the presenting illness; seizures and/or focal neurological fi ndings (with evidence of brain parenchyma involvement); CSF pleocytosis (more than four white blood cells per μL); electroencephalographic (EEG) fi ndings indicative of encephalitis; and abnormal results of neuroimaging (CT or MRI) suggestive of encephalitis.
The North and East Devon Multicentre Research Ethics Committee granted approval for the study (05/Q2102/22). We also obtained local research ethics committee approval and Research and Development approval from all participating centres. We obtained written informed consent from all patients or from their next of kin.
Procedures
Data recorded included demographic information, clinical fi ndings at presentation and discharge, immune status (eg, whether an individual was HIV positive or on immunosuppressive treatment), and results of laboratory, EEG, and neuroimaging testing. Samples obtained were from the CSF, blood, urine, stool, swabs from various sites (eg, throat or rectal), or from postmortem examination. We followed up patients at 6 months after discharge from hospital; outcome was scored according to the Glasgow outcome scale. 17 Poor outcome was defi ned as death or severe disability.
First-line testing (panel 1) included all commonly recognised causes of encephalitis, less commonly recognised causes in immunocompromised patients, and travel-related causes where appropriate. To obtain maximum diagnostic sensitivity, we used DNA or RNA and antibody assays. A multidisciplinary expert review of the clinical presentation, the results of tests, and the available samples from patients directed further investigation of undiagnosed patients, which included assays for second-line infectious causes, including those thought to be rare causes of encephalitis in the UK (panel 2) and screening of CSF samples for the presence of intrathecal production of antibodies. 18 Cases of Figure 1 : Study profi le *These patients might or might not have fulfi lled the inclusion criteria; those who were missed either died or were transferred out of hospital before further investigation could be done to fully assess eligibility or before consent could be obtained. †These patients were ineligible for case defi nition because of lack of imaging or EEG results. unknown cause were tested retrospectively for antibodies against voltage-gated potassium channels (n=62) and the NMDA receptor (n=48). 8, 11 All patients older than 50 years of age were tested for antibodies to West Nile virus. All patients who died and for whom the cause was unknown were tested for lyssaviruses. We classifi ed cases as confi rmed, probable, possible, or non-encephalitis with a defi nite alternative diagnosis, on the basis of aetiological case defi nitions. 19 We divided causes into the following categories: ADEM, antibodyassociated encephalitis (voltage-gated potassium channel and NMDA receptor), Mycobacterium tuberculosis, other bacterial encephalitis, herpes simplex virus; varicella zoster virus, and encephalitis of unknown cause.
Statistical analyses
We investigated diff erences in demographic and clinical variables and diff erences in laboratory and imaging results with Fisher's exact test. Factors associated with an infectious or immune-mediated cause, an unknown cause, death, and extended duration of hospital stay were studied in univariable and multivariable analyses. All variables with p of 0·2 or less in the univariable analyses were included in the multivariable regression models. Variables were added in a backwards stepwise procedure. A p value of less than 0·05 was deemed signifi cant. For all outcomes, apart from duration of hospital stay, logistic regression was used with associations assessed by odds ratios (OR) and their Wald CIs. For duration of hospital stay, a log transformation was used to correct bias; normal error regression was then used to adjust for any patients who died in hospital.
Role of the funding source
The sponsors of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had fi nal responsibility for the decision to submit for publication.
Results
We recruited 203 patients with encephalitis (fi gure 1), with a median age of 30 years (range 0-87); 109 (54%, 95% CI 47-61) were male. We identifi ed a cause for 128 cases (63%, 56-70). Specifi c triggers that caused most cases were herpes simplex virus, ADEM, antibodyassociated causes (NMDA receptor antibodies and voltage-gated potassium channel antibodies), varicella zoster virus, and M tuberculosis (table 1). There was strong evidence of variation in causes of encephalitis by age (p<0·001; fi gure 2) but not by sex (p=0·96).
No patient had indigenously acquired West Nile virus or lyssaviruses in the study-one patient who tested positive for herpes simplex virus by PCR while on holiday from Canada had West Nile virus IgM and IgG antibodies. Eight (35%) patients with ADEM had serological evidence of recent infection: four from Mycoplasma pneumoniae, one from infl uenza A, one from infl uenza B, one from group A streptococcus, and one from Campylobacter jejuni. One patient with ADEM . ¶Fever at time of admission. ||Coma was defi ned as a Glasgow outcome scale admission score of ≤8. **These symptoms were not actively sought in every case but documented if they were included in the "other" box of our questionnaire; thus, this represents the minimum proportion of patients with these symptoms or clinical signs because we only know if they were present or not known. † †Gastrointestinal symptoms were predominantly vomiting and diarrhoea; respiratory symptoms included cough, sore throat, sinusitis, runny nose, upper respiratory tract infection, and dyspnoea; and urinary symptoms included urinary tract infection, dysuria, urinary retention, and incontinence. ‡ ‡Pleocytosis was recorded if white-blood cell counts were >14 μL in neonates, >10 μL in infants (aged 1 month to 12 months), and >4 μL in all others.
§ §Abnormal protein defi ned as greater than 0·5 g/L. ¶ ¶Abnormal ratio defi ned as CSF:blood glucose less than 0·50. The presence of pleocytosis and abnormal protein in the CSF did not vary signifi cantly between patients with diff erent causes of encephalitis; however, the proportion of patients with an abnormal ratio of CSF to blood glucose did vary signifi cantly (table 3) . About 30% of patients with viral or immune-mediated encephalitis and an unknown cause had an abnormal ratio (table 3) . Many patients with bacterial causes of encephalitis had an abnormal glucose ratio (table 3) . Bacterial causes were also associated with increased white-cell counts (table 4) . 170 patients (84%) had CT, 169 (83%) MRI, and 120 (59%) EEG (table 3) . There was strong evidence of variation by cause in patients with abnormal CT and abnormal MRI fi ndings, but not with an abnormal EEG fi nding (table 3) . Patients with herpes simplex virus were most likely to have abnormal CT, whereas patients with antibody-associated and bacterial encephalitis were least likely to have abnormal CT. CT scans were abnormal in nearly a fi fth of patients with unknown cause. MRI was most likely to be abnormal in patients with ADEM and herpes simplex virus and least likely to be abnormal in patients with antibody-associated encephalitis and patients with bacterial causes. MRI scans were abnormal in about a third of patients with unknown cause. Outcome data were available for 198 patients (97%); fi ve patients were lost to follow-up. 24 patients died; death was most common in patients with M tuberculosis, varicella zoster virus, and antibody-associated encephalitis (table 5) . The worst outcome was seen in patients with antibodyassociated encephalitis or M tuberculosis (table 5) . The median length of hospital stay for these two groups was nearly three times longer than that for all cases. The outcome was poor in 15 (39%, 24-57) patients with herpes simplex virus and in 22 (31, 21-44) cases of unknown cause. The proportion of patients with poor outcome was higher in those with antibody-associated encephalitis than in those with bacterial encephalitis (p=0·05), ADEM (p=0·01), or encephalitis of unknown cause (p=0·03). Patients with ADEM had the best outcome (p=0·02), with more than two-thirds making a good recovery (table 5) . 158 patients (78%, 71-83) of all those with encephalitis received aciclovir; the median time from hospital admission to initiation of aciclovir was 1 day (range 0-93).
Patients with infectious causes were less likely to have respiratory symptoms but were more likely to have abnormal CSF protein concentrations than were patients with immune-mediated causes (table 3) . Patients with encephalitis of unknown cause were more likely to have photophobia but were less likely to have an abnormal CSF white cell count and focal neurological symptoms than were all cases of known cause (table 3 and table 6 ).
In logistic regression analyses for which death was an outcome, patients who died were more likely to be immunocompromised than were patients who did not die (table 6) . Similar fi ndings were reported when the length of hospital stay was used as the outcome measure after adjustment for potential confounders (data not shown).
Discussion
Less than half of patients presenting with encephalitis had a proven infectious cause in this study. Herpes simplex virus was the most common infectious cause, followed by varicella zoster virus and M tuberculosis. Thus, more than a quarter of patients were potentially treatable with aciclovir. This result confi rms previous reports of the important role of herpes simplex virus as a cause for sporadic acute infectious encephalitis, and of the increasing recognition of the role of varicella zoster virus, particularly in immunocompromised individuals. 20, 21 The identifi cation of M tuberculosis is clinically important because not only do these patients need specifi c treatment, but this cause is also associated with high mortality and poor outcome. Although most of these patients had fever, headache, and personality or behavioural changes, only a third had neck stiff ness. Most cases of M tuberculosis in this study were classifi ed as probable rather than confi rmed cases, indicating the diffi culty of detection of M tuberculosis in the CNS. 19, 22 1% of cases were caused by enteroviruses, similar to the results of a study in France, 23 but lower than that reported in a study in California. 24 Enterovirus encephalitis is more prevalent in children than in adults and is often mild, although disease associated with enterovirus 71 has high morbidity. 25 Diff erences in the proportion of children recruited or in the severity of illness might explain the diff erence between studies; in the California cohort, 45% were children, whereas 10% were children in the French study and 34% were children in this study. Fewer children than expected were recruited, perhaps because children are less likely than adults to have a lumbar puncture in the UK, one of our main methods of case ascertainment. 26 In view of the importance of accurate diagnosis to establish appropriate treatment, lumbar punctures in children with encephalitis are indicated.
About a fi fth of patients had immune-mediated encephalitis-mostly ADEM. Most studies of encephalitis have not distinguished ADEM from other acute encephalitides. However, identifi cation of such patients is important as treatment strategies involve immunomodulation. Patients with ADEM seem to meet the same case defi nition and present in similar ways to acute CSF=cerebrospinal fl uid. Age, sex, cause, fever, headache, seizures, lethargy, irritability, personality or behavioural change, stiff neck, coma, neurological signs (non-focal), gastrointestinal symptoms, rash, urinary symptoms, abnormal CSF:blood glucose ratio, abnormal CT, abnormal MRI, and abnormal EEG were additional variables included in the models and had no signifi cant association. To minimise loss of data and increase power, abnormal CSF:blood glucose ratio and coma were excluded from the infectious versus immune-mediated model; abnormal CSF:blood glucose ratio, coma, abnormal CT, and abnormal MRI were excluded from the known versus unknown model; abnormal CSF:blood glucose ratio and abnormal CT were excluded from the outcome model. We found 16 patients with antibody-associated encephalitis in otherwise unexplained cases. The results of this study highlights the epidemiological importance of these antibodies in a population-based cohort of patients; previous studies report case series, 9,10,28 although ten patients with NMDA receptor antibodies possibly associated with mycoplasma infections were identifi ed in the California Encephalitis Project. 28 Our detection of antibodies to both NMDA receptors and voltage-gated potassium channels in patients with suspected acute encephalitis-especially when associated with features of limbic encephalitis, prominent seizures, normal CT scans, absence of fever, and only mild CSF pleocytosissuggests that serological testing is important so that immunomodulation is instituted promptly, as this approach seems to be eff ective if given early. 8 Furthermore, underlying tumours should be sought because these encephalitides can be paraneoplastic. Although obtained prospectively, most cases of antibody-associated encephalitis in our study were diagnosed at the conclusion of the study when the samples received further testing. Therefore, the delay to diagnosis could account for the poor outcome observed in this group. We are now testing all patients, including those for whom a viral cause was identifi ed, to study whether antibodies could also have a role in infections. We did not detect any evidence of indigenous human West Nile virus infection in patients aged older than 50 years-the agegroup most at risk for neuroinvasive disease. 6 Although no indigenous cases of West Nile virus have been detected in the UK, this virus remains a concern because of climate change and vectors being present in the UK.
Prompt distinction between causes of acute encephalitis is essential to direct appropriate management. We confi rmed the well described clinical fi ndings for viral, bacterial, and mycobacterial causes. However, no single presenting symptom, sign, or CSF measurement could alone or in combination accurately separate one group from another. At presentation, only a few patients with proven infectious causes had neither fever nor CSF pleocytosis (24% and 11%, respectively, for herpes simplex virus); encephalitides cannot be excluded because patients are afebrile with normal CSF.
Seizures, especially in the absence of fever, should alert clinicians to antibody-associated encephalitis because this symptom commonly occurs in NMDA receptor and voltage-gated potassium channel encephalitides. 8, 9 Gastrointestinal symptoms were common in patients with bacterial encephalitides and might be associated with systemic infection, and in the ADEM group, these symptoms could be a manifestation of the precipitant infection. Similarly, the high rates of urinary symptoms noted in patients with ADEM or M tuberculosis infection might be associated with the tendency of these diseases to involve the spinal cord. The high rate of EEG abnormalities across the cohort is indicative of encephalopathy, a key requirement for recruitment into this study; but EEG did not help with distinction between causes. Our data provide further evidence that MRI is more sensitive than CT in revealing parenchymal change in encephalitis. However, we did not investigate the patterns or timings of appearance of MRI abnormalities within the diff erent groups. In keeping with most results from encephalitis studies, we detected slightly more male than female patients-whether men and boys are more susceptible to encephalitis, or indeed whether they have greater exposure to causative agents, needs to be established.
The number of deaths (12%) in this study was higher than that previously described in England for cases of viral encephalitis (7%). 1 This rate was also higher than the 2% and 7% rates described in North America, 13, 20 but was similar to those reported in a recent French study (10%). 23 We reported deaths in the community because patients were followed up 6 months after discharge from hospital. Although the study might have been biased towards more severe cases, the 10% mortality in those with encephalitis from herpes simplex virus was substantially lower than that reported in the aciclovir treatment trials (19-28%). 29, 30 Surprisingly, the outcome of cases of unknown cause was similar to those with herpes simplex virus-results from earlier studies have associated failure to identify a cause with a better outcome. 13, 31 Logistic regression analyses indicated that patients who died were more likely to be immunocompromised than were those who survived. 23 In addition to the substantial long-term morbidity present in many patients, their median hospital stay in this study was 28 days (IQR 15-62), indicating an important economic burden. 13 Systematic use of molecular diagnostics coupled with investigation for non-infectious causes might explain the low proportion of cases of unknown cause (37%) compared with the 60% previously described 1 -a lower proportion than that reported in most other studies. 2 Despite this fi nding, the proportion of cases with unknown cause was higher than that for any specifi c identifi ed cause. Explanations include the failure to identify non-encephalitic syndromic mimics, inadequate case investigation, and the presence of novel infectious or non-infectious encephalitis causes.
Although the three geographical areas encompassed both rural and urban communities, as well as areas of diff erent socioeconomic means, the age, sex, and ethnic origin of this cohort did not diff er from the general population in England. Bias towards ascertainment of severe encephalitis cases might be present because more than 60% of patients were transferred from a fi rst hospital of admission to more specialised units. Both mild and severe cases in study hospitals and severe cases transferred from other hospitals were studied; however, non-referred mild cases might not have been ascertained. Bias towards mild cases might also have occurred because of challenges in recruiting patients who died soon after admission, although we were only notifi ed of few such cases. Of all patients initially screened, about a third had proven non-encephalitis illnesses, which presented as mimics of encephalitis, as described in other studies. 32 Timing of sample acquisition during CNS infections aff ects test positivity and this factor might have contributed to failure to identify organisms. 33 The largest proportion of unknown causes was seen in children compared with older adults, as reported in other studies. 13 Cases of ADEM were unlikely to be among the group with unknown cause because most had ADEM excluded after MRI head scans. Although undescribed microbes or novel immune-mediated causes might contribute to cases classifi ed as unknown, non-encephalitic causes should also be considered. The poor outcome we report in those for whom a cause could not be identifi ed emphasises the importance of further research to defi ne causality in these patients.
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